SOURCE: Universal Detection Technology

April 30, 2008 16:05 ET

Universal Detection Technology Completes First Phase of Department of Homeland Security SAFETY Act Application for the BSM-2000

LOS ANGELES, CA--(Marketwire - April 30, 2008) - Universal Detection Technology (www.udetection.com) (OTCBB: UDTT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that it has completed the first Phase of the Department of Homeland Security's (DHS) SAFETY Act Application for the BSM-2000 airborne anthrax spore monitor. The SAFETY Act provides liability protection to help promote the creation, deployment and use of anti-terrorism technologies.

The Support Anti-terrorism by Fostering Effective Technologies Act of 2002 (SAFETY Act) provides important legal liability protections for providers of Qualified Anti-Terrorism Technologies -- whether they are products or services. The goal of the SAFETY Act is to encourage the development and deployment of new and innovative anti-terrorism products and services by providing liability protections. The SAFETY Act provides incentives for the development and deployment of anti-terrorism technologies by creating a system of "risk management" and a system of "litigation management." The purpose of the Act is to ensure that the threat of liability does not deter potential manufacturers or Sellers of anti-terrorism technologies from developing and commercializing technologies that could save lives.

"We are happy to announce the completion of the first phase of our application towards obtaining a SAFETY Act designation for the BSM-2000," said Mr. Jacques Tizabi, UDTT's Chief Executive Officer. "The process ensures that we continue our established dialogue with the Department of Homeland Security's SAFETY Act office towards obtaining this crucial designation for our technology," he added.

UDTT is a supplier of counter-terrorism services and technologies to private and government organizations. The Company owns the license to a patented technology developed at NASA's JPL and utilized in UDTT's BSM-2000 used for autonomous monitoring of the air for presence of airborne bacterial spores such as anthrax. UDTT also supplies detection kits for detection of up to 5 bioterrorism agents. Among the Company's other products are radiation detection systems, educational material & training DVDs, and antimicrobial chemicals.

For more information please visit www.udetection.com or

Email us at info@udetection.com

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bioterror 'smoke' detector that detects certain biohazard substances. For more information, please visit http://www.udetection.com.

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact Information